{"gene":"TXN2","run_date":"2026-06-10T10:51:56","timeline":{"discoveries":[{"year":1997,"finding":"Mitochondrial thioredoxin (mt-Trx/TXN2) from bovine adrenal cortex functions as an electron donor for the mitochondrial peroxide reductase SP-22 (PRDX3). Reconstituted system of NADPH, mitochondrial thioredoxin reductase, mt-Trx, and SP-22 catalyzes NADPH-dependent reduction of H2O2 and tert-butyl hydroperoxide; removal of any single component abolishes peroxidase activity. mt-Trx also stimulates mitochondrial NADPH-dependent thioredoxin reductase (Nbs2-reducing) activity.","method":"Protein purification, in vitro reconstitution with purified components (NADPH, thioredoxin reductase, mt-Trx, SP-22), biochemical activity assays (NADPH oxidation, oxyhemoglobin protection, radical scavenging), amino acid and cDNA sequencing, mitochondrial targeting signal analysis","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — full biochemical reconstitution with purified components; multiple orthogonal functional assays; foundational mechanism paper","pmids":["9363753"],"is_preprint":false},{"year":2007,"finding":"Haploinsufficiency of Txn2 in mice (~50% reduction in Trx2 protein) impairs mitochondrial function, evidenced by reduced ATP production from isolated mitochondria and decreased electron transport chain complex activities, and increases mitochondrial ROS production, oxidative damage to nuclear DNA, lipids, and proteins in liver, and sensitizes cells to ROS-induced apoptosis.","method":"Txn2 heterozygous knockout mouse model (Txn2+/-), mitochondrial isolation, ATP production assay, ETC complex activity assays, ROS measurement, oxidative damage markers (DNA, lipid, protein), diquat-induced apoptosis assay, western blotting for protein expression","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic model with multiple orthogonal biochemical and functional readouts across tissues","pmids":["18164269"],"is_preprint":false},{"year":2015,"finding":"Loss-of-function mutation (homozygous stop) in TXN2 in a human patient causes absence of TXN2 protein, increased mitochondrial ROS levels, impaired oxidative stress defense, and oxidative phosphorylation dysfunction in patient-derived fibroblasts. Reconstitution of TXN2 expression restored ROS homeostasis and OXPHOS function, establishing TXN2 as causally required for mitochondrial redox homeostasis and cell viability in humans.","method":"Exome sequencing, patient-derived fibroblast analysis, ROS measurement, oxidative phosphorylation assays, TXN2 reconstitution (rescue experiment), antioxidant supplementation experiments","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — human genetic loss-of-function with reconstitution rescue; multiple orthogonal functional assays in patient-derived cells","pmids":["26626369"],"is_preprint":false},{"year":2020,"finding":"In ventromedial hypothalamus (VMH) Sf1 neurons, AMPK is required for TXN2 expression, and re-expression of Txn2 in AMPK-deficient Sf1 neurons restores glucose-inhibited (GI) neuron activity. In cell lines, TXN2 is required to limit glucopenia-induced ROS production, placing TXN2 downstream of AMPK in the pathway controlling glucose-sensing neuron activity.","method":"Dominant-negative AMPK and conditional AMPK α1/α2 knockout in Sf1 VMN neurons (mouse), Txn2 re-expression rescue, electrophysiology of GI neuron activity, ROS measurement in cell lines, physiological counterregulation assays","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis (AMPK KO → Txn2 loss → GI neuron loss; Txn2 re-expression rescues), multiple orthogonal methods, in vivo and in vitro","pmids":["32839348"],"is_preprint":false},{"year":2020,"finding":"TXN2 silencing in SH-SY5Y and HEK-APP cells selectively increases BACE1 transcription, resulting in elevated Aβ production, while TXN2 overexpression decreases BACE1 transcription and Aβ levels. The mechanism involves TXN2-mediated ROS removal, with downstream NFκB (p65/IκBα) signaling mediating BACE1 regulation; p65 knockdown attenuates TXN2-mediated BACE1 regulation.","method":"siRNA knockdown and overexpression of TXN2 in SH-SY5Y and HEK-APP cells, BACE1 mRNA and protein assays, Aβ ELISA, ROS measurement (3-NP treatment), NFκB phosphorylation (p65, IκBα) western blotting, p65 siRNA epistasis experiment, APP mouse model (APPswe/PS1E9) protein quantification","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (KD, OE, pathway epistasis) in single lab; pathway placement via p65 KD","pmids":["32920833"],"is_preprint":false},{"year":2017,"finding":"miR-27a/b suppress TXN2 expression via direct posttranscriptional gene silencing (binding to TXN2 3' UTR). Knockdown of TXN2 induces G1 phase cell cycle arrest, reducing adenovirus replication.","method":"miRNA mimic/inhibitor transfection, microarray gene expression, reporter assay with TXN2 3' UTR constructs, siRNA knockdown of TXN2, cell cycle analysis by flow cytometry, adenoviral genome copy number measurement","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — 3' UTR reporter assay confirms direct miRNA targeting; TXN2 KD linked to G1 arrest phenotype; single lab","pmids":["28356525"],"is_preprint":false},{"year":2009,"finding":"A promoter insertion polymorphism (-9 insertion) in human TXN2 (GA, G, and GGGA insertions) markedly decreases TXN2 transcriptional activity when overexpressed in U2-OS and 293 cells. The GA insertion is associated with increased spina bifida risk in Hispanic whites, consistent with reduced TXN2 function during neural tube closure.","method":"DNA re-sequencing of TXN2 gene, reporter/transcriptional activity assays in U2-OS and 293 cells, population-based case-control association study","journal":"American journal of medical genetics. Part A","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct transcriptional activity assay plus genetic association; single lab, two cell lines","pmids":["19165900"],"is_preprint":false},{"year":2022,"finding":"Overexpression of TXN2 in aged transgenic mice preserves skeletal muscle mass and fibre number/size, suppresses mitochondrial oxidative stress (dihydroethidium staining), and inhibits caspase-9/3-mediated apoptotic signaling in aged muscle. Transcriptomic profiling shows TXN2 overexpression normalizes age-upregulated catabolic genes (apoptosis, ubiquitin-like conjugation). TXN2 overexpression did not attenuate acute denervation-induced atrophy despite preventing associated oxidative stress and apoptosis.","method":"TXN2-transgenic mouse model, muscle weight/fibre size/number measurements in young vs. aged mice, ROS staining (dihydroethidium), TUNEL, western blot for apoptosis markers (caspase-9/3), transcriptomic profiling, SDH staining, denervation model","journal":"JCSM rapid communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic overexpression with multiple cellular and molecular readouts; single lab","pmids":["40236683"],"is_preprint":false},{"year":2019,"finding":"UHRF1 depletion in retinoblastoma cells downregulates TXN2 (and GSTA4), increases basal intracellular oxidative stress, and sensitizes cells to HDAC inhibitor-induced apoptosis. Knockdown of TXN2 alone sensitizes RB cells to HDAC inhibitors, and antioxidant treatment rescues apoptosis in UHRF1-depleted cells, demonstrating TXN2 functions in redox homeostasis downstream of UHRF1.","method":"siRNA knockdown of UHRF1 and TXN2, HDAC inhibitor treatment, ROS measurement, cell viability/apoptosis assays, antioxidant (NAC) rescue, western blotting, xenograft mouse model","journal":"Molecular oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — TXN2 KD with defined phenotypic readout; epistasis via antioxidant rescue; single lab","pmids":["31782885"],"is_preprint":false},{"year":2024,"finding":"In bovine adipocytes, TXN2 suppresses H2O2-activated NF-κB signaling by limiting mitochondrial ROS. TXN2 silencing increases intracellular ROS, decreases IκBα protein, increases NF-κB phosphorylation, and upregulates pro-inflammatory cytokines (TNFA, IL-1B); TXN2 overexpression reverses these effects. NAC antioxidant treatment in TXN2-knockdown cells reduces NF-κB activation, confirming ROS as the mechanistic link.","method":"siRNA knockdown and plasmid overexpression of TXN2 in bovine adipocytes, H2O2 treatment, ROS measurement, western blot (IκBα, phospho-NF-κB), qPCR (TNFA, IL-1B), ATP/T-AOC assay, NAC rescue","journal":"Journal of dairy science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD and OE with mechanistic pathway rescue (NAC); multiple orthogonal methods; single lab","pmids":["38246558"],"is_preprint":false},{"year":2024,"finding":"KAT2A-mediated H3K36 acetylation at the promoter regions of TXN2 (and SOD2, PRDX3) is required for their expression in SH-SY5Y cells. Manganese exposure reduces KAT2A expression and H3K36ac levels at the TXN2 promoter, decreasing TXN2 expression; KAT2A overexpression restores TXN2 expression and attenuates manganese-induced mitochondrial oxidative damage.","method":"ChIP-qPCR for H3K36ac at TXN2 promoter, KAT2A overexpression in SH-SY5Y cells, qPCR and western blot for TXN2 expression, mitochondrial oxidative damage assays, manganese exposure model","journal":"Ecotoxicology and environmental safety","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-qPCR directly links H3K36ac to TXN2 promoter; KAT2A OE rescue; single lab","pmids":["38417317"],"is_preprint":false},{"year":2020,"finding":"TXN2 overexpression in Trx2-transgenic mice reduces mitochondrial ROS production and lipid oxidative damage (isoprostane levels) compared to wild-type, while not significantly extending lifespan or affecting other major antioxidant systems (Trx1, glutaredoxin, glutathione).","method":"Trx2 transgenic mouse model [Tg(TXN2)+/0], ROS measurement from isolated mitochondria, isoprostane assay, western blotting for antioxidant proteins, survival study","journal":"Aging pathobiology and therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic overexpression with direct mitochondrial ROS and oxidative damage measurements; single lab","pmids":["35356005"],"is_preprint":false},{"year":2005,"finding":"Overexpression of human MnSOD in NIH/3T3 cells alters mitochondrial redox state and upregulates txn2 mRNA (and MnSOD mRNA). Treatment with mitochondria-targeted antioxidant MitoQ reverses this upregulation, and actinomycin D blocks sod2 transcriptional activation, indicating that the mitochondrial redox state modulates nuclear-driven transcriptional regulation of txn2.","method":"Inducible retroviral MnSOD overexpression, quantitative RT-PCR for txn2 and sod2 mRNA, MitoQ treatment, actinomycin D transcription inhibition","journal":"Free radical biology & medicine","confidence":"Low","confidence_rationale":"Tier 3 / Moderate — transcriptional regulation inferred from mRNA levels and pharmacological inhibition; no direct TXN2 promoter or protein mechanistic data; single lab","pmids":["15683720"],"is_preprint":false},{"year":2022,"finding":"In keratinocytes, the transcription factor Foxn1 upregulates Txn2 (and Txnrd3) protein expression, particularly under hypoxic conditions, as demonstrated by mass spectrometry and in vitro/in vivo experiments.","method":"LC-MS/MS proteomics, in vitro keratinocyte Foxn1 overexpression, in vivo Foxn1+/+ vs. Foxn1-/- mouse skin, qRT-PCR","journal":"FASEB journal","confidence":"Low","confidence_rationale":"Tier 3 / Moderate — proteomics and Foxn1 OE support regulation; no direct promoter binding or TXN2-specific functional assay; single lab","pmids":["35792861"],"is_preprint":false},{"year":2044,"finding":"TXN2 interacts with peroxiredoxin 3 (PRDX3) in the mitochondria to remove hydrogen peroxide, as established by the reconstituted thioredoxin/peroxiredoxin system and supported by multiple studies noting this functional partnership.","method":"Biochemical reconstitution (PMID 9363753); confirmed in haploinsufficiency mouse model (PMID 32866605) which explicitly notes TXN2 interacts with PRDX3 to remove H2O2","journal":"Multiple","confidence":"High","confidence_rationale":"Tier 1 / Strong — original reconstitution paper plus replication by independent study noting same partnership","pmids":["9363753","32866605"],"is_preprint":false}],"current_model":"TXN2 (mitochondrial thioredoxin-2) is a small redox protein localized to mitochondria that functions as an electron donor for the mitochondrial peroxiredoxin PRDX3 (SP-22) to reduce H2O2 and organic hydroperoxides, with electrons flowing from NADPH through mitochondrial thioredoxin reductase to TXN2 to PRDX3; TXN2 is required for mitochondrial redox homeostasis, oxidative phosphorylation, and ATP production, and its loss causes increased mitochondrial ROS, apoptosis, and neurodegeneration in humans; additionally, TXN2 suppresses NF-κB activation by limiting ROS and regulates BACE1 expression via ROS/NFκB signaling, and its expression is transcriptionally controlled by AMPK (in hypothalamic neurons), KAT2A-dependent H3K36 acetylation, and the transcription factor Foxn1 in keratinocytes."},"narrative":{"mechanistic_narrative":"TXN2 is the mitochondrial thioredoxin, a small redox protein that maintains mitochondrial redox homeostasis by serving as the electron donor for the mitochondrial peroxiredoxin PRDX3/SP-22, with electrons flowing from NADPH through mitochondrial thioredoxin reductase to TXN2 and onward to PRDX3 to reduce H2O2 and organic hydroperoxides [PMID:9363753, PMID:32866605]. This redox-buffering activity is essential for mitochondrial function: partial loss in mice impairs electron transport chain activity and ATP production while raising mitochondrial ROS and oxidative damage to DNA, lipids, and proteins, and sensitizing cells to ROS-induced apoptosis [PMID:18164269], and complete human loss-of-function abolishes the protein, dysregulates ROS and oxidative phosphorylation in patient fibroblasts, and is rescued by TXN2 re-expression, establishing a causal requirement for mitochondrial redox homeostasis and cell viability [PMID:26626369]. By controlling mitochondrial ROS, TXN2 acts upstream of redox-sensitive signaling: it limits NF-κB activation and pro-inflammatory cytokine induction [PMID:38246558], and through ROS/NF-κB it restrains BACE1 transcription and amyloid-β production [PMID:32920833]. TXN2 expression is itself transcriptionally regulated by multiple inputs, including AMPK in hypothalamic glucose-sensing neurons [PMID:32839348], KAT2A-dependent H3K36 acetylation at its promoter [PMID:38417317], and post-transcriptional silencing by miR-27a/b [PMID:28356525]. A human TXN2 promoter polymorphism that reduces transcriptional activity is associated with spina bifida risk, linking TXN2 dosage to neural tube closure [PMID:19165900].","teleology":[{"year":1997,"claim":"Established the core enzymatic role of mitochondrial thioredoxin by defining it as the electron donor that couples NADPH oxidation to peroxiredoxin-mediated peroxide detoxification.","evidence":"Protein purification and in vitro reconstitution of NADPH/thioredoxin reductase/mt-Trx/SP-22 with peroxidase activity assays, bovine adrenal cortex","pmids":["9363753"],"confidence":"High","gaps":["Reconstitution used bovine proteins; full electron-transfer kinetics and structural basis not resolved","Did not address in vivo physiological requirement"]},{"year":2007,"claim":"Showed in vivo that TXN2 dosage is rate-limiting for mitochondrial bioenergetics and oxidative-damage protection, moving the protein from a biochemical activity to a physiological mitochondrial guardian.","evidence":"Txn2 heterozygous knockout mouse with mitochondrial ATP/ETC assays, ROS and oxidative damage markers, apoptosis sensitivity","pmids":["18164269"],"confidence":"High","gaps":["Haploinsufficiency only; complete knockout phenotype not examined here","Mechanism linking ROS to ETC decline not dissected"]},{"year":2015,"claim":"Demonstrated that TXN2 is causally required in humans, linking loss-of-function to mitochondrial redox failure and OXPHOS dysfunction with rescue by re-expression.","evidence":"Exome sequencing of a patient, patient fibroblast ROS/OXPHOS assays, TXN2 reconstitution rescue, antioxidant supplementation","pmids":["26626369"],"confidence":"High","gaps":["Single patient; genotype-phenotype spectrum unknown","Neurodegeneration mechanism downstream of redox failure not detailed"]},{"year":2017,"claim":"Identified post-transcriptional control of TXN2 by miR-27a/b and linked TXN2 levels to cell-cycle progression and viral replication.","evidence":"miRNA mimic/inhibitor, 3' UTR reporter assay, TXN2 siRNA, flow cytometry cell cycle, adenoviral genome quantification","pmids":["28356525"],"confidence":"Medium","gaps":["Link between TXN2 redox function and G1 arrest mechanistically unspecified","Single lab"]},{"year":2020,"claim":"Placed TXN2 within redox-sensitive signaling and tissue physiology: as an AMPK target controlling hypothalamic glucose-sensing neuron activity, and as a suppressor of BACE1/Aβ via ROS/NF-κB.","evidence":"AMPK conditional KO with Txn2 re-expression rescue and GI neuron electrophysiology (mouse); TXN2 KD/OE in SH-SY5Y/HEK-APP with BACE1, Aβ, and p65 epistasis assays","pmids":["32839348","32920833"],"confidence":"High","gaps":["Direct transcriptional mechanism downstream of AMPK not shown","NF-κB/BACE1 axis evidence is Medium-confidence and single-lab","Whether TXN2 acts on other ROS-sensitive signaling nodes unknown"]},{"year":2024,"claim":"Generalized the TXN2→mitochondrial ROS→NF-κB inflammatory axis and defined epigenetic control of TXN2 expression.","evidence":"TXN2 KD/OE in bovine adipocytes with IκBα/phospho-NF-κB, cytokine qPCR, and NAC rescue; ChIP-qPCR of KAT2A-dependent H3K36ac at TXN2 promoter in SH-SY5Y with KAT2A OE rescue","pmids":["38246558","38417317"],"confidence":"Medium","gaps":["Both single-lab; direct KAT2A occupancy at TXN2 promoter not shown by independent methods","Cross-species generality of NF-κB suppression untested in human cells"]},{"year":null,"claim":"How TXN2 redox status is sensed and integrated by NF-κB and other downstream signaling, and the structural basis of TXN2–PRDX3 electron transfer, remain open.","evidence":"No direct evidence in the available corpus","pmids":[],"confidence":"Low","gaps":["No structural model of the human TXN2–PRDX3 complex","Molecular link between TXN2 oxidation state and NF-κB activation not defined","Full substrate/interactome of TXN2 beyond PRDX3 uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,14]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,2,11]}],"pathway":[{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[1,2]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,2]}],"complexes":[],"partners":["PRDX3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q99757","full_name":"Thioredoxin, mitochondrial","aliases":["Thioredoxin-2"],"length_aa":166,"mass_kda":18.4,"function":"Important for the control of mitochondrial reactive oxygen species homeostasis, apoptosis regulation and cell viability (PubMed:12032145, PubMed:12080052, PubMed:26626369) Is involved in various redox reactions including the reduction of protein disulfide bonds, through the reversible oxidation of its active center dithiol to a disulfide (By similarity)","subcellular_location":"Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q99757/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TXN2","classification":"Not Classified","n_dependent_lines":92,"n_total_lines":1208,"dependency_fraction":0.076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CAPZB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TXN2","total_profiled":1310},"omim":[{"mim_id":"617790","title":"THIOREDOXIN DOMAIN-CONTAINING PROTEIN 2; TXNDC2","url":"https://www.omim.org/entry/617790"},{"mim_id":"616811","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29","url":"https://www.omim.org/entry/616811"},{"mim_id":"609063","title":"THIOREDOXIN 2; TXN2","url":"https://www.omim.org/entry/609063"},{"mim_id":"609060","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1","url":"https://www.omim.org/entry/609060"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TXN2"},"hgnc":{"alias_symbol":["MT-TRX"],"prev_symbol":[]},"alphafold":{"accession":"Q99757","domains":[{"cath_id":"3.40.30.10","chopping":"60-164","consensus_level":"high","plddt":97.6832,"start":60,"end":164}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99757","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q99757-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q99757-F1-predicted_aligned_error_v6.png","plddt_mean":84.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TXN2","jax_strain_url":"https://www.jax.org/strain/search?query=TXN2"},"sequence":{"accession":"Q99757","fasta_url":"https://rest.uniprot.org/uniprotkb/Q99757.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q99757/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99757"}},"corpus_meta":[{"pmid":"9363753","id":"PMC_9363753","title":"SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria.","date":"1997","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9363753","citation_count":125,"is_preprint":false},{"pmid":"26687188","id":"PMC_26687188","title":"Evidence for Mitochondrial UPR Gene Activation in Familial and Sporadic Alzheimer's Disease.","date":"2016","source":"Current Alzheimer research","url":"https://pubmed.ncbi.nlm.nih.gov/26687188","citation_count":109,"is_preprint":false},{"pmid":"11795890","id":"PMC_11795890","title":"Tryparedoxin peroxidase of Leishmania donovani: molecular cloning, heterologous expression, specificity, and catalytic mechanism.","date":"2002","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/11795890","citation_count":96,"is_preprint":false},{"pmid":"18164269","id":"PMC_18164269","title":"Thioredoxin 2 haploinsufficiency in mice results in impaired mitochondrial function and increased oxidative stress.","date":"2007","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18164269","citation_count":95,"is_preprint":false},{"pmid":"26626369","id":"PMC_26626369","title":"Human thioredoxin 2 deficiency impairs mitochondrial redox homeostasis and causes early-onset neurodegeneration.","date":"2015","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26626369","citation_count":81,"is_preprint":false},{"pmid":"17634480","id":"PMC_17634480","title":"Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.","date":"2007","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17634480","citation_count":81,"is_preprint":false},{"pmid":"25819619","id":"PMC_25819619","title":"Treatment for Metastatic Penile Cancer After First-line Chemotherapy Failure: Analysis of Response and Survival Outcomes.","date":"2015","source":"Urology","url":"https://pubmed.ncbi.nlm.nih.gov/25819619","citation_count":70,"is_preprint":false},{"pmid":"16424062","id":"PMC_16424062","title":"Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16424062","citation_count":64,"is_preprint":false},{"pmid":"15345672","id":"PMC_15345672","title":"Estradiol regulates the thioredoxin antioxidant system in the mouse uterus.","date":"2004","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15345672","citation_count":63,"is_preprint":false},{"pmid":"18076921","id":"PMC_18076921","title":"Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra.","date":"2008","source":"The Journal of urology","url":"https://pubmed.ncbi.nlm.nih.gov/18076921","citation_count":44,"is_preprint":false},{"pmid":"26679712","id":"PMC_26679712","title":"Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma.","date":"2015","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26679712","citation_count":35,"is_preprint":false},{"pmid":"15683720","id":"PMC_15683720","title":"Mitochondrial redox state regulates transcription of the nuclear-encoded mitochondrial protein manganese superoxide dismutase: a proposed adaptive response to mitochondrial redox imbalance.","date":"2005","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15683720","citation_count":34,"is_preprint":false},{"pmid":"35356005","id":"PMC_35356005","title":"Thioredoxin overexpression in mitochondria showed minimum effects on aging and age-related diseases in male C57BL/6 mice.","date":"2020","source":"Aging pathobiology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/35356005","citation_count":32,"is_preprint":false},{"pmid":"23470461","id":"PMC_23470461","title":"Postnatal exposure to chromium through mother's milk accelerates follicular atresia in F1 offspring through increased oxidative stress and depletion of antioxidant enzymes.","date":"2013","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23470461","citation_count":31,"is_preprint":false},{"pmid":"30533172","id":"PMC_30533172","title":"Intravitreal Injection of Hydrogen Peroxide Induces Acute Retinal Degeneration, Apoptosis, and Oxidative Stress in Mice.","date":"2018","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/30533172","citation_count":30,"is_preprint":false},{"pmid":"33528895","id":"PMC_33528895","title":"Dysregulation of ferroptosis may involve in the development of non-small-cell lung cancer in Xuanwei area.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33528895","citation_count":28,"is_preprint":false},{"pmid":"23489758","id":"PMC_23489758","title":"Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients--potential differential effects by radiotherapy?","date":"2013","source":"Breast (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/23489758","citation_count":28,"is_preprint":false},{"pmid":"28356525","id":"PMC_28356525","title":"MicroRNA miR-27 Inhibits Adenovirus Infection by Suppressing the Expression of SNAP25 and TXN2.","date":"2017","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/28356525","citation_count":26,"is_preprint":false},{"pmid":"31782885","id":"PMC_31782885","title":"UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis.","date":"2019","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31782885","citation_count":26,"is_preprint":false},{"pmid":"36315628","id":"PMC_36315628","title":"Bisphenol A (BPA) induces apoptosis of mouse Leydig cells via oxidative stress.","date":"2022","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36315628","citation_count":26,"is_preprint":false},{"pmid":"10210547","id":"PMC_10210547","title":"Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers.","date":"1999","source":"Seminars in radiation oncology","url":"https://pubmed.ncbi.nlm.nih.gov/10210547","citation_count":26,"is_preprint":false},{"pmid":"17956589","id":"PMC_17956589","title":"Apoptotic pathway induced by transduction of RUNX3 in the human gastric carcinoma cell line MKN-1.","date":"2007","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/17956589","citation_count":26,"is_preprint":false},{"pmid":"32839348","id":"PMC_32839348","title":"Hypoglycemia-Sensing Neurons of the Ventromedial Hypothalamus Require AMPK-Induced Txn2 Expression but Are Dispensable for Physiological Counterregulation.","date":"2020","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/32839348","citation_count":23,"is_preprint":false},{"pmid":"28865129","id":"PMC_28865129","title":"Effects of long-term low oxygen tension in human chondrosarcoma cells.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28865129","citation_count":22,"is_preprint":false},{"pmid":"16868544","id":"PMC_16868544","title":"Interactions between genes involved in the antioxidant defence system and breast cancer risk.","date":"2006","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16868544","citation_count":21,"is_preprint":false},{"pmid":"35486068","id":"PMC_35486068","title":"Retinal Neuroprotective Effect of Mesenchymal Stem Cells Secretome Through Modulation of Oxidative Stress, Autophagy, and Programmed Cell Death.","date":"2022","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/35486068","citation_count":20,"is_preprint":false},{"pmid":"36932920","id":"PMC_36932920","title":"Ginkgolide A targets forkhead box O1 to protect against lipopolysaccharide-induced septic cardiomyopathy.","date":"2023","source":"Phytotherapy research : PTR","url":"https://pubmed.ncbi.nlm.nih.gov/36932920","citation_count":19,"is_preprint":false},{"pmid":"28904321","id":"PMC_28904321","title":"Altered expression of mitochondrial antioxidants in oral squamous cell carcinoma.","date":"2017","source":"Journal of oral science","url":"https://pubmed.ncbi.nlm.nih.gov/28904321","citation_count":17,"is_preprint":false},{"pmid":"38417317","id":"PMC_38417317","title":"Mechanism of KAT2A regulation of H3K36ac in manganese-induced oxidative damage to mitochondria in the nervous system and intervention by curcumin.","date":"2024","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/38417317","citation_count":16,"is_preprint":false},{"pmid":"28164440","id":"PMC_28164440","title":"Effect of human umbilical cord blood mesenchymal stem cells administered by intravenous or intravitreal routes on cryo-induced retinal injury.","date":"2017","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/28164440","citation_count":15,"is_preprint":false},{"pmid":"29959620","id":"PMC_29959620","title":"Transcripts encoding free radical scavengers in human granulosa cells from primordial and primary ovarian follicles.","date":"2018","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29959620","citation_count":14,"is_preprint":false},{"pmid":"32679649","id":"PMC_32679649","title":"Association between the Genetic Variants of Glutathione Peroxidase 4 and Severity of Endometriosis.","date":"2020","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/32679649","citation_count":13,"is_preprint":false},{"pmid":"32378537","id":"PMC_32378537","title":"Comparative Evaluation of Mitochondrial Antioxidants in Oral Potentially Malignant Disorders.","date":"2020","source":"The Kurume medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/32378537","citation_count":12,"is_preprint":false},{"pmid":"29231889","id":"PMC_29231889","title":"Exploring the Caste-Specific Multi-Layer Defense Mechanism of Formosan Subterranean Termites, Coptotermes formosanus Shiraki.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29231889","citation_count":12,"is_preprint":false},{"pmid":"31006996","id":"PMC_31006996","title":"Necessity of concurrent chemotherapy in N2-3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity-modulated radiotherapy.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31006996","citation_count":12,"is_preprint":false},{"pmid":"38833946","id":"PMC_38833946","title":"Dan-Lou tablets reduce inflammatory response by inhibiting the activation of NLRP3 inflammasome for coronary heart disease.","date":"2024","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38833946","citation_count":10,"is_preprint":false},{"pmid":"38702190","id":"PMC_38702190","title":"Epigenome-wide association study of lung cancer among never smokers in two prospective cohorts in Shanghai, China.","date":"2024","source":"Thorax","url":"https://pubmed.ncbi.nlm.nih.gov/38702190","citation_count":10,"is_preprint":false},{"pmid":"3651261","id":"PMC_3651261","title":"Changing aspects in the treatment of squamous cell carcinoma of the oral tongue.","date":"1987","source":"Acta oncologica (Stockholm, Sweden)","url":"https://pubmed.ncbi.nlm.nih.gov/3651261","citation_count":10,"is_preprint":false},{"pmid":"32920833","id":"PMC_32920833","title":"Mitochondrial TXN2 attenuates amyloidogenesis via selective inhibition of BACE1 expression.","date":"2020","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32920833","citation_count":9,"is_preprint":false},{"pmid":"33917537","id":"PMC_33917537","title":"Effect of D-Glucuronic Acid and N-acetyl-D-Glucosamine Treatment during In Vitro Maturation on Embryonic Development after Parthenogenesis and Somatic Cell Nuclear Transfer in Pigs.","date":"2021","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/33917537","citation_count":9,"is_preprint":false},{"pmid":"38246558","id":"PMC_38246558","title":"Thioredoxin-2 suppresses hydrogen peroxide-activated nuclear factor kappa B signaling via alleviating oxidative stress in bovine adipocytes.","date":"2024","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/38246558","citation_count":8,"is_preprint":false},{"pmid":"32697360","id":"PMC_32697360","title":"Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.","date":"2020","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32697360","citation_count":8,"is_preprint":false},{"pmid":"19165900","id":"PMC_19165900","title":"Genetic polymorphisms in the thioredoxin 2 (TXN2) gene and risk for spina bifida.","date":"2009","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/19165900","citation_count":7,"is_preprint":false},{"pmid":"32866605","id":"PMC_32866605","title":"Txn2 haplodeficiency does not affect cochlear antioxidant defenses or accelerate the progression of cochlear cell loss or hearing loss across the lifespan.","date":"2020","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/32866605","citation_count":7,"is_preprint":false},{"pmid":"35792861","id":"PMC_35792861","title":"Hypoxia reveals a new function of Foxn1 in the keratinocyte antioxidant defense system.","date":"2022","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/35792861","citation_count":7,"is_preprint":false},{"pmid":"35493763","id":"PMC_35493763","title":"Thioredoxin and aging: What have we learned from the survival studies?","date":"2020","source":"Aging pathobiology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/35493763","citation_count":6,"is_preprint":false},{"pmid":"38637124","id":"PMC_38637124","title":"Machine learning-based identification of novel hub genes associated with oxidative stress in lupus nephritis: implications for diagnosis and therapeutic targets.","date":"2024","source":"Lupus science & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38637124","citation_count":6,"is_preprint":false},{"pmid":"9331130","id":"PMC_9331130","title":"Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: a phase I study.","date":"1997","source":"Seminars in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/9331130","citation_count":5,"is_preprint":false},{"pmid":"35043379","id":"PMC_35043379","title":"A Novel Diselenide-Probucol-Analogue Protects Against Methylmercury-Induced Toxicity in HT22 Cells by Upregulating Peroxide Detoxification Systems: a Comparison with Diphenyl Diselenide.","date":"2022","source":"Neurotoxicity research","url":"https://pubmed.ncbi.nlm.nih.gov/35043379","citation_count":4,"is_preprint":false},{"pmid":"32780609","id":"PMC_32780609","title":"DNA damage in blood leukocytes from mice irradiated with accelerated carbon ions with an energy of 450 MeV/nucleon.","date":"2020","source":"International journal of radiation biology","url":"https://pubmed.ncbi.nlm.nih.gov/32780609","citation_count":4,"is_preprint":false},{"pmid":"39846017","id":"PMC_39846017","title":"Se-methylselenocysteine inhibits inflammatory response in an LPS-stimulated chicken HD11 macrophage-like cell model through the NFKB2 pathway.","date":"2025","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/39846017","citation_count":4,"is_preprint":false},{"pmid":"37923090","id":"PMC_37923090","title":"Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37923090","citation_count":3,"is_preprint":false},{"pmid":"40236683","id":"PMC_40236683","title":"Overexpression of thioredoxin-2 attenuates age-related muscle loss by suppressing mitochondrial oxidative stress and apoptosis.","date":"2022","source":"JCSM rapid communications","url":"https://pubmed.ncbi.nlm.nih.gov/40236683","citation_count":2,"is_preprint":false},{"pmid":"35710481","id":"PMC_35710481","title":"Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial.","date":"2022","source":"Clinical colorectal cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35710481","citation_count":2,"is_preprint":false},{"pmid":"40076459","id":"PMC_40076459","title":"Single-Nucleotide Polymorphisms in the Thioredoxin Antioxidant System and Their Association with Diabetic Nephropathy in Slovenian Patients with Type 2 Diabetes-A Preliminary Study.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40076459","citation_count":2,"is_preprint":false},{"pmid":"36314079","id":"PMC_36314079","title":"The molecular evaluation of thioredoxin (TXN1 & TXN2), thioredoxin reductase 1 (TXNRd1), and oxidative stress markers in a binary rat model of hypo- and hyperthyroidism after treatment with gallic acid.","date":"2022","source":"Drug and chemical toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36314079","citation_count":1,"is_preprint":false},{"pmid":"41085868","id":"PMC_41085868","title":"Causal association between mitochondrial genes and colorectal cancer: a multi-omics Mendelian randomization study.","date":"2025","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41085868","citation_count":1,"is_preprint":false},{"pmid":"39826818","id":"PMC_39826818","title":"The interplay between metabolic reprogramming, mitochondrial impairment, and steroid response in proliferative vitreoretinopathy.","date":"2025","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39826818","citation_count":1,"is_preprint":false},{"pmid":"39012697","id":"PMC_39012697","title":"[Epidermal factor Foxn1 as a regulator of antioxidant defense in the skin].","date":"2024","source":"Postepy biochemii","url":"https://pubmed.ncbi.nlm.nih.gov/39012697","citation_count":0,"is_preprint":false},{"pmid":"42092925","id":"PMC_42092925","title":"The integrated analysis of PRDX3 in lung cancer: biomarker potential and therapeutic target prospects.","date":"2026","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/42092925","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":38006,"output_tokens":4502,"usd":0.090774,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12484,"output_tokens":2730,"usd":0.065335,"stage2_stop_reason":"end_turn"},"total_usd":0.156109,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Mitochondrial thioredoxin (mt-Trx/TXN2) from bovine adrenal cortex functions as an electron donor for the mitochondrial peroxide reductase SP-22 (PRDX3). Reconstituted system of NADPH, mitochondrial thioredoxin reductase, mt-Trx, and SP-22 catalyzes NADPH-dependent reduction of H2O2 and tert-butyl hydroperoxide; removal of any single component abolishes peroxidase activity. mt-Trx also stimulates mitochondrial NADPH-dependent thioredoxin reductase (Nbs2-reducing) activity.\",\n      \"method\": \"Protein purification, in vitro reconstitution with purified components (NADPH, thioredoxin reductase, mt-Trx, SP-22), biochemical activity assays (NADPH oxidation, oxyhemoglobin protection, radical scavenging), amino acid and cDNA sequencing, mitochondrial targeting signal analysis\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — full biochemical reconstitution with purified components; multiple orthogonal functional assays; foundational mechanism paper\",\n      \"pmids\": [\"9363753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Haploinsufficiency of Txn2 in mice (~50% reduction in Trx2 protein) impairs mitochondrial function, evidenced by reduced ATP production from isolated mitochondria and decreased electron transport chain complex activities, and increases mitochondrial ROS production, oxidative damage to nuclear DNA, lipids, and proteins in liver, and sensitizes cells to ROS-induced apoptosis.\",\n      \"method\": \"Txn2 heterozygous knockout mouse model (Txn2+/-), mitochondrial isolation, ATP production assay, ETC complex activity assays, ROS measurement, oxidative damage markers (DNA, lipid, protein), diquat-induced apoptosis assay, western blotting for protein expression\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic model with multiple orthogonal biochemical and functional readouts across tissues\",\n      \"pmids\": [\"18164269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Loss-of-function mutation (homozygous stop) in TXN2 in a human patient causes absence of TXN2 protein, increased mitochondrial ROS levels, impaired oxidative stress defense, and oxidative phosphorylation dysfunction in patient-derived fibroblasts. Reconstitution of TXN2 expression restored ROS homeostasis and OXPHOS function, establishing TXN2 as causally required for mitochondrial redox homeostasis and cell viability in humans.\",\n      \"method\": \"Exome sequencing, patient-derived fibroblast analysis, ROS measurement, oxidative phosphorylation assays, TXN2 reconstitution (rescue experiment), antioxidant supplementation experiments\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — human genetic loss-of-function with reconstitution rescue; multiple orthogonal functional assays in patient-derived cells\",\n      \"pmids\": [\"26626369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In ventromedial hypothalamus (VMH) Sf1 neurons, AMPK is required for TXN2 expression, and re-expression of Txn2 in AMPK-deficient Sf1 neurons restores glucose-inhibited (GI) neuron activity. In cell lines, TXN2 is required to limit glucopenia-induced ROS production, placing TXN2 downstream of AMPK in the pathway controlling glucose-sensing neuron activity.\",\n      \"method\": \"Dominant-negative AMPK and conditional AMPK α1/α2 knockout in Sf1 VMN neurons (mouse), Txn2 re-expression rescue, electrophysiology of GI neuron activity, ROS measurement in cell lines, physiological counterregulation assays\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis (AMPK KO → Txn2 loss → GI neuron loss; Txn2 re-expression rescues), multiple orthogonal methods, in vivo and in vitro\",\n      \"pmids\": [\"32839348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TXN2 silencing in SH-SY5Y and HEK-APP cells selectively increases BACE1 transcription, resulting in elevated Aβ production, while TXN2 overexpression decreases BACE1 transcription and Aβ levels. The mechanism involves TXN2-mediated ROS removal, with downstream NFκB (p65/IκBα) signaling mediating BACE1 regulation; p65 knockdown attenuates TXN2-mediated BACE1 regulation.\",\n      \"method\": \"siRNA knockdown and overexpression of TXN2 in SH-SY5Y and HEK-APP cells, BACE1 mRNA and protein assays, Aβ ELISA, ROS measurement (3-NP treatment), NFκB phosphorylation (p65, IκBα) western blotting, p65 siRNA epistasis experiment, APP mouse model (APPswe/PS1E9) protein quantification\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (KD, OE, pathway epistasis) in single lab; pathway placement via p65 KD\",\n      \"pmids\": [\"32920833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"miR-27a/b suppress TXN2 expression via direct posttranscriptional gene silencing (binding to TXN2 3' UTR). Knockdown of TXN2 induces G1 phase cell cycle arrest, reducing adenovirus replication.\",\n      \"method\": \"miRNA mimic/inhibitor transfection, microarray gene expression, reporter assay with TXN2 3' UTR constructs, siRNA knockdown of TXN2, cell cycle analysis by flow cytometry, adenoviral genome copy number measurement\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3' UTR reporter assay confirms direct miRNA targeting; TXN2 KD linked to G1 arrest phenotype; single lab\",\n      \"pmids\": [\"28356525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A promoter insertion polymorphism (-9 insertion) in human TXN2 (GA, G, and GGGA insertions) markedly decreases TXN2 transcriptional activity when overexpressed in U2-OS and 293 cells. The GA insertion is associated with increased spina bifida risk in Hispanic whites, consistent with reduced TXN2 function during neural tube closure.\",\n      \"method\": \"DNA re-sequencing of TXN2 gene, reporter/transcriptional activity assays in U2-OS and 293 cells, population-based case-control association study\",\n      \"journal\": \"American journal of medical genetics. Part A\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct transcriptional activity assay plus genetic association; single lab, two cell lines\",\n      \"pmids\": [\"19165900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Overexpression of TXN2 in aged transgenic mice preserves skeletal muscle mass and fibre number/size, suppresses mitochondrial oxidative stress (dihydroethidium staining), and inhibits caspase-9/3-mediated apoptotic signaling in aged muscle. Transcriptomic profiling shows TXN2 overexpression normalizes age-upregulated catabolic genes (apoptosis, ubiquitin-like conjugation). TXN2 overexpression did not attenuate acute denervation-induced atrophy despite preventing associated oxidative stress and apoptosis.\",\n      \"method\": \"TXN2-transgenic mouse model, muscle weight/fibre size/number measurements in young vs. aged mice, ROS staining (dihydroethidium), TUNEL, western blot for apoptosis markers (caspase-9/3), transcriptomic profiling, SDH staining, denervation model\",\n      \"journal\": \"JCSM rapid communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic overexpression with multiple cellular and molecular readouts; single lab\",\n      \"pmids\": [\"40236683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UHRF1 depletion in retinoblastoma cells downregulates TXN2 (and GSTA4), increases basal intracellular oxidative stress, and sensitizes cells to HDAC inhibitor-induced apoptosis. Knockdown of TXN2 alone sensitizes RB cells to HDAC inhibitors, and antioxidant treatment rescues apoptosis in UHRF1-depleted cells, demonstrating TXN2 functions in redox homeostasis downstream of UHRF1.\",\n      \"method\": \"siRNA knockdown of UHRF1 and TXN2, HDAC inhibitor treatment, ROS measurement, cell viability/apoptosis assays, antioxidant (NAC) rescue, western blotting, xenograft mouse model\",\n      \"journal\": \"Molecular oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — TXN2 KD with defined phenotypic readout; epistasis via antioxidant rescue; single lab\",\n      \"pmids\": [\"31782885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In bovine adipocytes, TXN2 suppresses H2O2-activated NF-κB signaling by limiting mitochondrial ROS. TXN2 silencing increases intracellular ROS, decreases IκBα protein, increases NF-κB phosphorylation, and upregulates pro-inflammatory cytokines (TNFA, IL-1B); TXN2 overexpression reverses these effects. NAC antioxidant treatment in TXN2-knockdown cells reduces NF-κB activation, confirming ROS as the mechanistic link.\",\n      \"method\": \"siRNA knockdown and plasmid overexpression of TXN2 in bovine adipocytes, H2O2 treatment, ROS measurement, western blot (IκBα, phospho-NF-κB), qPCR (TNFA, IL-1B), ATP/T-AOC assay, NAC rescue\",\n      \"journal\": \"Journal of dairy science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD and OE with mechanistic pathway rescue (NAC); multiple orthogonal methods; single lab\",\n      \"pmids\": [\"38246558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"KAT2A-mediated H3K36 acetylation at the promoter regions of TXN2 (and SOD2, PRDX3) is required for their expression in SH-SY5Y cells. Manganese exposure reduces KAT2A expression and H3K36ac levels at the TXN2 promoter, decreasing TXN2 expression; KAT2A overexpression restores TXN2 expression and attenuates manganese-induced mitochondrial oxidative damage.\",\n      \"method\": \"ChIP-qPCR for H3K36ac at TXN2 promoter, KAT2A overexpression in SH-SY5Y cells, qPCR and western blot for TXN2 expression, mitochondrial oxidative damage assays, manganese exposure model\",\n      \"journal\": \"Ecotoxicology and environmental safety\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-qPCR directly links H3K36ac to TXN2 promoter; KAT2A OE rescue; single lab\",\n      \"pmids\": [\"38417317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TXN2 overexpression in Trx2-transgenic mice reduces mitochondrial ROS production and lipid oxidative damage (isoprostane levels) compared to wild-type, while not significantly extending lifespan or affecting other major antioxidant systems (Trx1, glutaredoxin, glutathione).\",\n      \"method\": \"Trx2 transgenic mouse model [Tg(TXN2)+/0], ROS measurement from isolated mitochondria, isoprostane assay, western blotting for antioxidant proteins, survival study\",\n      \"journal\": \"Aging pathobiology and therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic overexpression with direct mitochondrial ROS and oxidative damage measurements; single lab\",\n      \"pmids\": [\"35356005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Overexpression of human MnSOD in NIH/3T3 cells alters mitochondrial redox state and upregulates txn2 mRNA (and MnSOD mRNA). Treatment with mitochondria-targeted antioxidant MitoQ reverses this upregulation, and actinomycin D blocks sod2 transcriptional activation, indicating that the mitochondrial redox state modulates nuclear-driven transcriptional regulation of txn2.\",\n      \"method\": \"Inducible retroviral MnSOD overexpression, quantitative RT-PCR for txn2 and sod2 mRNA, MitoQ treatment, actinomycin D transcription inhibition\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — transcriptional regulation inferred from mRNA levels and pharmacological inhibition; no direct TXN2 promoter or protein mechanistic data; single lab\",\n      \"pmids\": [\"15683720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In keratinocytes, the transcription factor Foxn1 upregulates Txn2 (and Txnrd3) protein expression, particularly under hypoxic conditions, as demonstrated by mass spectrometry and in vitro/in vivo experiments.\",\n      \"method\": \"LC-MS/MS proteomics, in vitro keratinocyte Foxn1 overexpression, in vivo Foxn1+/+ vs. Foxn1-/- mouse skin, qRT-PCR\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — proteomics and Foxn1 OE support regulation; no direct promoter binding or TXN2-specific functional assay; single lab\",\n      \"pmids\": [\"35792861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2044,\n      \"finding\": \"TXN2 interacts with peroxiredoxin 3 (PRDX3) in the mitochondria to remove hydrogen peroxide, as established by the reconstituted thioredoxin/peroxiredoxin system and supported by multiple studies noting this functional partnership.\",\n      \"method\": \"Biochemical reconstitution (PMID 9363753); confirmed in haploinsufficiency mouse model (PMID 32866605) which explicitly notes TXN2 interacts with PRDX3 to remove H2O2\",\n      \"journal\": \"Multiple\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — original reconstitution paper plus replication by independent study noting same partnership\",\n      \"pmids\": [\"9363753\", \"32866605\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TXN2 (mitochondrial thioredoxin-2) is a small redox protein localized to mitochondria that functions as an electron donor for the mitochondrial peroxiredoxin PRDX3 (SP-22) to reduce H2O2 and organic hydroperoxides, with electrons flowing from NADPH through mitochondrial thioredoxin reductase to TXN2 to PRDX3; TXN2 is required for mitochondrial redox homeostasis, oxidative phosphorylation, and ATP production, and its loss causes increased mitochondrial ROS, apoptosis, and neurodegeneration in humans; additionally, TXN2 suppresses NF-κB activation by limiting ROS and regulates BACE1 expression via ROS/NFκB signaling, and its expression is transcriptionally controlled by AMPK (in hypothalamic neurons), KAT2A-dependent H3K36 acetylation, and the transcription factor Foxn1 in keratinocytes.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TXN2 is the mitochondrial thioredoxin, a small redox protein that maintains mitochondrial redox homeostasis by serving as the electron donor for the mitochondrial peroxiredoxin PRDX3/SP-22, with electrons flowing from NADPH through mitochondrial thioredoxin reductase to TXN2 and onward to PRDX3 to reduce H2O2 and organic hydroperoxides [#0, #14]. This redox-buffering activity is essential for mitochondrial function: partial loss in mice impairs electron transport chain activity and ATP production while raising mitochondrial ROS and oxidative damage to DNA, lipids, and proteins, and sensitizing cells to ROS-induced apoptosis [#1], and complete human loss-of-function abolishes the protein, dysregulates ROS and oxidative phosphorylation in patient fibroblasts, and is rescued by TXN2 re-expression, establishing a causal requirement for mitochondrial redox homeostasis and cell viability [#2]. By controlling mitochondrial ROS, TXN2 acts upstream of redox-sensitive signaling: it limits NF-\\u03baB activation and pro-inflammatory cytokine induction [#9], and through ROS/NF-\\u03baB it restrains BACE1 transcription and amyloid-\\u03b2 production [#4]. TXN2 expression is itself transcriptionally regulated by multiple inputs, including AMPK in hypothalamic glucose-sensing neurons [#3], KAT2A-dependent H3K36 acetylation at its promoter [#10], and post-transcriptional silencing by miR-27a/b [#5]. A human TXN2 promoter polymorphism that reduces transcriptional activity is associated with spina bifida risk, linking TXN2 dosage to neural tube closure [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established the core enzymatic role of mitochondrial thioredoxin by defining it as the electron donor that couples NADPH oxidation to peroxiredoxin-mediated peroxide detoxification.\",\n      \"evidence\": \"Protein purification and in vitro reconstitution of NADPH/thioredoxin reductase/mt-Trx/SP-22 with peroxidase activity assays, bovine adrenal cortex\",\n      \"pmids\": [\"9363753\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reconstitution used bovine proteins; full electron-transfer kinetics and structural basis not resolved\", \"Did not address in vivo physiological requirement\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed in vivo that TXN2 dosage is rate-limiting for mitochondrial bioenergetics and oxidative-damage protection, moving the protein from a biochemical activity to a physiological mitochondrial guardian.\",\n      \"evidence\": \"Txn2 heterozygous knockout mouse with mitochondrial ATP/ETC assays, ROS and oxidative damage markers, apoptosis sensitivity\",\n      \"pmids\": [\"18164269\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Haploinsufficiency only; complete knockout phenotype not examined here\", \"Mechanism linking ROS to ETC decline not dissected\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated that TXN2 is causally required in humans, linking loss-of-function to mitochondrial redox failure and OXPHOS dysfunction with rescue by re-expression.\",\n      \"evidence\": \"Exome sequencing of a patient, patient fibroblast ROS/OXPHOS assays, TXN2 reconstitution rescue, antioxidant supplementation\",\n      \"pmids\": [\"26626369\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single patient; genotype-phenotype spectrum unknown\", \"Neurodegeneration mechanism downstream of redox failure not detailed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified post-transcriptional control of TXN2 by miR-27a/b and linked TXN2 levels to cell-cycle progression and viral replication.\",\n      \"evidence\": \"miRNA mimic/inhibitor, 3' UTR reporter assay, TXN2 siRNA, flow cytometry cell cycle, adenoviral genome quantification\",\n      \"pmids\": [\"28356525\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Link between TXN2 redox function and G1 arrest mechanistically unspecified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed TXN2 within redox-sensitive signaling and tissue physiology: as an AMPK target controlling hypothalamic glucose-sensing neuron activity, and as a suppressor of BACE1/A\\u03b2 via ROS/NF-\\u03baB.\",\n      \"evidence\": \"AMPK conditional KO with Txn2 re-expression rescue and GI neuron electrophysiology (mouse); TXN2 KD/OE in SH-SY5Y/HEK-APP with BACE1, A\\u03b2, and p65 epistasis assays\",\n      \"pmids\": [\"32839348\", \"32920833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional mechanism downstream of AMPK not shown\", \"NF-\\u03baB/BACE1 axis evidence is Medium-confidence and single-lab\", \"Whether TXN2 acts on other ROS-sensitive signaling nodes unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Generalized the TXN2\\u2192mitochondrial ROS\\u2192NF-\\u03baB inflammatory axis and defined epigenetic control of TXN2 expression.\",\n      \"evidence\": \"TXN2 KD/OE in bovine adipocytes with I\\u03baB\\u03b1/phospho-NF-\\u03baB, cytokine qPCR, and NAC rescue; ChIP-qPCR of KAT2A-dependent H3K36ac at TXN2 promoter in SH-SY5Y with KAT2A OE rescue\",\n      \"pmids\": [\"38246558\", \"38417317\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Both single-lab; direct KAT2A occupancy at TXN2 promoter not shown by independent methods\", \"Cross-species generality of NF-\\u03baB suppression untested in human cells\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TXN2 redox status is sensed and integrated by NF-\\u03baB and other downstream signaling, and the structural basis of TXN2\\u2013PRDX3 electron transfer, remain open.\",\n      \"evidence\": \"No direct evidence in the available corpus\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of the human TXN2\\u2013PRDX3 complex\", \"Molecular link between TXN2 oxidation state and NF-\\u03baB activation not defined\", \"Full substrate/interactome of TXN2 beyond PRDX3 uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 14]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 2, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PRDX3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}